Did you mean: Hari-Ng Tao
Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series
…, LJ Ying, CL Ma, SB Li, HY Wang, S Zhang, HN Gao… - bmj, 2020 - bmj.com
Objective To study the clinical characteristics of patients in Zhejiang province, China, infected
with the 2019 severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) responsible …
with the 2019 severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) responsible …
Clinical findings in 111 cases of influenza A (H7N9) virus infection
HN Gao, HZ Lu, B Cao, B Du, H Shang… - … England Journal of …, 2013 - Mass Medical Soc
Background During the spring of 2013, a novel avian-origin influenza A (H7N9) virus emerged
and spread among humans in China. Data were lacking on the clinical characteristics of …
and spread among humans in China. Data were lacking on the clinical characteristics of …
Risk factors analysis of COVID-19 patients with ARDS and prediction based on machine learning
W Xu, NN Sun, HN Gao, ZY Chen, Y Yang, B Ju… - Scientific reports, 2021 - nature.com
COVID-19 is a newly emerging infectious disease, which is generally susceptible to human
beings and has caused huge losses to people's health. Acute respiratory distress syndrome (…
beings and has caused huge losses to people's health. Acute respiratory distress syndrome (…
[HTML][HTML] Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial
…, C Dong, B Ying, GP Sheng, CF Qin, HN Gao… - The Lancet …, 2022 - thelancet.com
Background Safe and effective vaccines are urgently needed to end the COVID-19 pandemic
caused by SARS-CoV-2 infection. We aimed to assess the preliminary safety, tolerability, …
caused by SARS-CoV-2 infection. We aimed to assess the preliminary safety, tolerability, …
Fatal outcome in a liver transplant recipient with COVID‐19
JF Huang, KI Zheng, J George, HN Gao… - American Journal of …, 2020 - Wiley Online Library
Liver injury is common in patients with COVID‐19, but little is known about its clinical
presentation and severity in the context of liver transplant. We describe a case of COVID‐19 in a …
presentation and severity in the context of liver transplant. We describe a case of COVID‐19 in a …
[HTML][HTML] Successful treatment of avian-origin influenza A (H7N9) infection using convalescent plasma
XX Wu, HN Gao, HB Wu, XM Peng, HL Ou… - International Journal of …, 2015 - Elsevier
In January 2015, there was an outbreak of avian-origin influenza A (H7N9) virus in Zhejiang
Province, China. A 45-year-old man was admitted to the First Affiliated Hospital of Zhejiang …
Province, China. A 45-year-old man was admitted to the First Affiliated Hospital of Zhejiang …
A prediction model based on machine learning for diagnosing the early COVID-19 patients
NN Sun, Y Yang, LL Tang, YN Dai, HN Gao, HY Pan… - MedRxiv, 2020 - medrxiv.org
With the dramatically fast spread of COVID-9, real-time reverse transcription polymerase chain
reaction (RT-PCR) test has become the gold standard method for confirmation of COVID-…
reaction (RT-PCR) test has become the gold standard method for confirmation of COVID-…
Ebolavirus vaccines: progress in the fight against Ebola virus disease
XX Wu, HP Yao, NP Wu, HN Gao, HB Wu… - Cellular Physiology and …, 2015 - karger.com
Ebolaviruses are highly infectious pathogens that cause lethal Ebola virus disease (EVD) in
humans and non-human primates (NHPs). Due to their high pathogenicity and …
humans and non-human primates (NHPs). Due to their high pathogenicity and …
[HTML][HTML] Clinical significance of C-reactive protein values in antibiotic treatment for pyogenic liver abscess
HN Gao, WX Yuan, MF Yang, H Zhao… - World journal of …, 2010 - ncbi.nlm.nih.gov
AIM: To investigate the clinical significance of C-reactive protein (CRP) values in determining
the endpoint of antibiotic treatment for liver abscess after drainage. METHODS: The …
the endpoint of antibiotic treatment for liver abscess after drainage. METHODS: The …
[HTML][HTML] Phase I study of a non-S2P SARS-CoV-2 mRNA vaccine LVRNA009 in Chinese adults
…, XH Wu, RJ Pei, F Deng, GP Jiang, YH Li, HN Gao… - Vaccine, 2023 - Elsevier
Background COVID-19 caused by SARS-CoV-2 is a great threat to public health. We present
the safety and immunogenicity data from a phase I trial in China of an mRNA vaccine (…
the safety and immunogenicity data from a phase I trial in China of an mRNA vaccine (…
Did you mean to search for: Hari-Ng Tao